We are live on
!
Find out more
Parnassus Investments Portfolio holdings
AUM
$37.4B
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$21.4B
AUM Growth
+$1.18B
(+5.8%)
Cap. Flow
+$753M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
35.9%
Holding
84
New
2
Increased
52
Reduced
18
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$474M |
| 2 |
Clorox
CLX
|
+$429M |
| 3 |
Gilead Sciences
GILD
|
+$320M |
| 4 |
Novartis
NVS
|
+$287M |
| 5 |
PX
Praxair Inc
PX
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$486M |
| 2 |
Micron Technology
MU
|
+$463M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$275M |
| 4 |
Fortive
FTV
|
+$271M |
| 5 |
Sysco
SYY
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.98% |
| 2 | Technology | 17.14% |
| 3 | Industrials | 13.16% |
| 4 | Financials | 12.46% |
| 5 | Consumer Staples | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lam Research
LRCX
$400B
| $12.8M | 0.06% |
1,000,000
-3,500,000
| -78% | -$41.1M |
|
|
BEL
77
DELISTED
Belmond Ltd.
BEL
| $12.1M | 0.06% |
1,000,000
+500,000
| +100% | +$6.58M |
|
|
AGN.PRA
78
DELISTED
Allergan plc
AGN.PRA
| $2.46M | 0.01% |
2,900
| – | – |
|
79
Alibaba
BABA
$279B
| $539K | ﹤0.01% |
5,000
| – | – |
|
80
TSMC
TSM
$2.28T
| $328K | ﹤0.01% |
10,000
| – | – |
|
81
Keysight
KEYS
$56.6B
| $289K | ﹤0.01% |
8,000
+4,000
| +100% | +$149K |
|
82
Insperity
NSP
$1.88B
| – | – |
-474,740
| Closed | -$16.8M |
|
|
CCC
83
DELISTED
Calgon Carbon Corp
CCC
| – | – |
-1,260,000
| Closed | -$21.4M |
|
Similar funds
ECSS
PIF
TWC
Parnassus Investments's Q1 2017 Portfolio in Review
As of Q1 2017, Parnassus Investments held 84 positions worth $21.4B, up 5.8% from $20.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parnassus Investments deployed $753M of net new capital in Q1 2017, opening 2 new positions and adding to 52 existing holdings. Its largest new stake was Clorox: 3,314,774 shares worth $434M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Applied Materials, an estimated $486M trimmed.
- Parnassus Investments's largest Q1 2017 buy was Clorox: 3,314,774 shares worth $434M.
- Parnassus Investments added most to McKesson in Q1 2017, an estimated $474M increase.
- Parnassus Investments's biggest Q1 2017 reduction was Applied Materials, cutting an estimated $486M.
- Parnassus Investments fully exited Calgon Carbon Corp in Q1 2017, selling an estimated $21.4M.
- Parnassus Investments's ten largest holdings make up 36% of its $21.4B portfolio in Q1 2017.
- Parnassus Investments opened 2 new positions and closed 2 in Q1 2017.
- Parnassus Investments's portfolio value rose 5.8% quarter-over-quarter to $21.4B.
Based on Parnassus Investments's 13F filing for Q1 2017, filed 1 May 2017.